In a revolutionary leap for cancer therapy, researchers have developed a 3D-printed implant that delivers chemotherapy drugs directly to tumors. The technology, designed for precision-targeted treatment, bypasses traditional systemic methods that often result in severe side effects.
The implants are biodegradable and can be customized for each patient based on tumor location, size, and drug requirements. By focusing the drug’s delivery directly into the cancerous mass, this method enhances efficacy while reducing collateral damage to healthy tissues.
The 3D-printed structures are embedded with tiny channels or reservoirs, designed to slowly release the drug over time, ensuring sustained dosage at the tumor site. With clinical trials already underway, experts believe this method could mark a major shift in how aggressive cancers—like glioblastoma and pancreatic tumors—are treated.
This development demonstrates not only the power of additive manufacturing in medicine but also opens the door for patient-specific cancer solutions that were previously unimaginable.
